Pulse Explorar nav.journalClub Debates Tendencias Investigadores

Join discussions, follow papers, and never miss your next session.

Download on theApp Store

Inicio Explorar nav.journalClub Tendencias

⌘+K

Selenium and the Course of Mild Graves' Orbitopathy | Synapse

May 18, 2011Open Access

Selenium and the Course of Mild Graves' Orbitopathy

Puntos clave

Los puntos clave no están disponibles para este artículo en este momento.

Resumen

Selenium administration significantly improved quality of life, reduced ocular involvement, and slowed progression of the disease in patients with mild Graves' orbitopathy. (Funded by the University of Pisa and the Italian Ministry for Education, University and Research; EUGOGO Netherlands Trial Register number, NTR524.).

Leer artículo completoexternamente

Preguntar a la IA

Me gusta

Guardar

Compartir

Ver artículo completo

Preguntar a la IA

Me gusta

Guardar

Compartir

Ver artículo completo

Cite This Study

Marcocci et al. (Wed,) studied this question.

synapsesocial.com/papers/69d95e588988aeabbe6850ee https://doi.org/https://doi.org/10.1056/nejmoa1012985

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Supplementation with antioxidants in the treatment of Graves' disease; the effect on glutathione peroxidase activity and concentration of selenium2004 · 97 citations
2Methimazole and propylthiouracil inhibit the oxygen free radical-induced expression of a 72 kilodalton heat shock protein in Graves' retroocular fibroblasts1992 · 84 citations
3Methimazole and propylthiouracil inhibit the oxygen free radical- induced expression of a 72 kilodalton heat shock protein in Graves' retroocular fibroblasts1992 · 45 citations
4Clinical activity score as a guide in the management of patients with Graves' ophthalmopathy1997 · 996 citations
5Inhibitory Effect of Pentoxifylline on HLA-DR Expression and Glycosaminoglycan Synthesis by Retrobulbar Fibroblasts1998 · 19 citations